Hong Kong, China
United States
Overview
IPO
All
Main Board
GEM
Calendar

MARKET INDEX

H

HSI

IDXHKG

23,472.34
-281.50 -1.19%

H

HSCEI

IDXHKG

7,899.87
-81.67 -1.02%

H

HSTECH

IDXHKG

3,739.32
-62.32 -1.64%

All Stocks

More
No.
Symbol/Name
% Change
Last Price
1

P

Peiport Holdings

02885

+21.89%
3.230
2

I

IMPACT Therapeutics

07630

+21.07%
11.290
3

C

China Tianbao Group Development

01427

+20.77%
0.157
4

Z

Zhuguang Holdings Group

01176

+16.67%
0.014
5

H

Horizon Construction Development

09930

+15.12%
0.495
6

I

IWS Group Holdings

06663

+13.25%
0.470
7

L

Lai Sun Development

00488

+12.96%
0.610
8

S

Sky Blue 11

01010

+12.12%
0.037
9

J

JLogo Holdings

08527

+12.07%
0.325
10

S

Sichuan Neautus Traditional Chinese Medicine

02206

+10.48%
80.100

Main Board

More
No.
Symbol/Name
% Change
Last Price
1

P

Peiport Holdings

02885

+21.89%
3.230
2

I

IMPACT Therapeutics

07630

+21.07%
11.290
3

C

China Tianbao Group Development

01427

+20.77%
0.157
4

Z

Zhuguang Holdings Group

01176

+16.67%
0.014
5

H

Horizon Construction Development

09930

+15.12%
0.495
6

I

IWS Group Holdings

06663

+13.25%
0.470
7

L

Lai Sun Development

00488

+12.96%
0.610
8

S

Sky Blue 11

01010

+12.12%
0.037
9

S

Sichuan Neautus Traditional Chinese Medicine

02206

+10.48%
80.100
10

L

Left Field Printing Group

01540

+10.08%
0.710

GEM

More
No.
Symbol/Name
% Change
Last Price
1

J

JLogo Holdings

08527

+12.07%
0.325
2

Q

Qingda Oriental Group

08115

+10.11%
5.010
3

C

China Demeter Financial Investments

08120

+9.69%
1.585
4

K

Kong Shum Smart Management Group (Holdings)

08181

+8.89%
0.049
5

Z

Zijing International Financial Holdings

08340

+8.33%
1.300
6

B

Basetrophy Group Holdings

08460

+6.94%
0.385
7

C

China Biotech Services Holdings

08037

+5.71%
0.370
8

M

Max Sight Group Holdings

08483

+4.88%
0.430
9

T

TL Natural Gas Holdings

08536

+4.48%
0.233
10

C

China Brilliant Global

08026

+4.46%
3.750

Calendar

More
Earnings
Dividends
Splits
No.
Symbol/Name
Release Time
EPS Estimate
Last EPS

IPO Center

More
Available
To Be Listed
Submitted
Listed
No.
Symbol/Name
Price Range
Min Amount to Apply
Deadline for Cash
1

B

Beijing Sinotau International Pharmaceutical Technology

09941

--
--
--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities. This should not be construed as an investment advice and does not constitute an offer, solicitation, opinion, or any guarantee of any investment product, nor does it constitute any investment recommendation. Investments involve risks, Investment products prices are subject to fluctuation and may rise or fall (including the possibility of loss of the capital invested). Past performance is not indicative of future results. Before making any investment decision, investors should carefully consider your own risk tolerance, financial situation, investment experience, and objectives, or consult professional investment advisors to make a rational decision.
Language

English

©2026 Webull Securities Limited. All rights reserved.